Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue

Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance